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Background 
The genus Capripoxvirus (CaPV) within the family Poxviridae com-
prises three closely related viruses, sheep poxvirus (SPPV), goat 
poxvirus (GTPV) and lumpy skin disease virus (LSDV) causing sheep 
pox (SPP), goat pox (GTP) and lumpy skin disease (LSD) in small ru-
minants and cattle respectively. LSD has emerged in Europe in 2015 
and first incursions of SPP in the European Union were reported 
in Bulgaria and Greece in 2013. Live attenuated SPPV vaccines are 
widely used in many countries to control SPP and GTP. With the in-
creasing number of reports on SPP in previously vaccinated sheep 
herds, it is imperative to develop new diagnostic tools for differen-
tiation of SPPV field strains from attenuated vaccine strains.
Objective
This work aimed at identifying appropriate diagnostic targets to de-
velop assays for the rapid and accurate differentiation SPPV vaccine 
strains from SPPV field isolates and other CaPVs.
Methodology 
To identify a suitable molecular target for the development of these 
assays, the full genomes of several SPPV vaccines strains and SPPV 
field isolates were compared. A unique 84-base pair nucleotide dele-
tion located between the DNA ligase and the B22R gene was exploit-
ed to develop a gel-based PCR, and a region containing a 48bp de-
letion within the B22R gene of SPPV vaccines strains only, as well as 
species-specific nucleotide difference between SPPV field isolates, 
GTPV and LSDV, was targeted to develop a HRM assay. 
Results
The gel-based assay was readily able to differentiate SPPV vaccines 
from field isolates. However, this method alone could not differen-
tiate SPPV field isolates from GTPV and LSDV. In contrast, the HRM 
based method allowed the differentiation of SPPV vaccines from 
field isolates and further enabled the genotyping of capripoxviruses 
isolates. Out of 61 samples tested, we identified 4 SPPV vaccines, 
14 SPPV field isolates, 11 GTPVs and 32 LSDVs. The two assays were 
both sensitive and specific and in agreement with the sequencing 
data of the tested samples.
Conclusion
The assays described herein are reliable and rapid methods for 
the differentiation of SPPV Vaccines from SPPV field isolates. While 
the gel based assay needs to be combined with capripoxvirus spe-
cies-specific assays, the HRM assay stands alone as a tool to differen-
tiate SPPV vaccines from field isolates and simultaneously genotype 
SPPVs, GTPVs and LSDVs. The methods are suited for routine use 
during outbreak investigations in both capripoxvirus enzootic and 
disease-free countries.
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Background
Lumpy Skin Disease (LSD), Sheeppox (SPP) and Goatpox (GTP) are 
contagious diseases of ruminants with a devastating impact on the 
livestock industry and trade, also affecting the living conditions of 
poor rural and small farmers. LSD, SPP, GTP were mainly confined 
to Africa, the Middle East and Asia, with some sporadic incursions 
of SPP in Greece and Bulgaria. However, in 2015 the first incursions 
of LSD occurred in the European Union. Due to their potential for 
rapid spreading, a highly sensitive and specific serological method 
for active and passive surveillance of SPP, GTP and LSD is needed. In 
addition, such a tool could serve for post-vaccination monitoring. 
Objective
The aim of this work was to evaluate recombinants proteins of the 
capripoxvirus virion for use in an indirect ELISA (iELISA) to detect 
anti-capripox antibodies in vaccinated and naturally infected small 
ruminants and cattle sera.  
Method 
We have identified, characterized, expressed and purified capripox-
virus virion surface protein (CVSP) that react to positive SPP, GTP 
and LSD sera samples by Western Blot and iELISA. The iELISA was 
further optimised and evaluated using sera samples from vaccinat-
ed, experimentally and naturally infected sheep, goat and cattle.
Results
Twenty experimentally infected positive and 130 negative LSD, SPP 
and GTP sera samples were tested and correctly identified using 
the CVSP iELISA. We tested sera collected at multiple time points 
from several LSD experimentally infected animals. We observed a 
time dependant increased in anti-LSD antibody production after 
day 14 post infection. For specificity, five ORF positive sera were 
tested. None of the ORF positive sera was positive in the CVSP iELISA. 
A number of field sera collected during capripoxvirus outbreaks and 
vaccination campaigns from animals with known infection/vaccina-
tion status were tested by the CVSP iELISA and compared to the virus 
neutralization assay. The complete dataset and results of the field 
test evaluation will be presented. 
Conclusion
As capripox diseases spread, and to strengthen disease surveillance 
and control programmes, there is an ever-increasing need for rapid 
and effective antibody detection assays. The CVSP tested in the pres-
ent study demonstrated to be good antigen candidates for the de-
velopment of sensitive and specific serological assays. The prototype 
iELISA developed has the potential to be used as an effective and 
rapid method for capripoxvirus antibody detection in vaccinated, 
experimentally and naturally infected sheep, goat and cattle sera. 
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